Please cite this paper as:
Liu, M.-T. and Reiter, R.J. 2020. Molecular mechanisms of melatonin’s protection against high-LET radiation: implications for space travel. Melatonin Research. 3, 4 (Oct. 2020), 503-514. DOI:https://doi.org/https://doi.org/10.32794/mr11250075.
Molecular mechanisms of melatonin’s protection against high-LET radiation: implications for space travel
Mu-Tai Liu1, Russel J. Reiter2*
1Department of Radiology, Yuanpei University, Taiwan
2Department of Cell Systems and Anatomy, Long School of medicine, UT Health San Antonio,
San Antonio, Texas
*Correspondence: reiter@uthscsa.edu, Tel: +01 2105673859
Running title: Melatonin protection against high-LET radiation
Received: June 5, 2020; Accepted: September 5, 2020
ABSTRACT
During a deep space mission, the central nervous system (CNS) and other organs are exposed to galactic cosmic rays and solar particle events. Health risks associated with various organs and systems are important issues in a long-term spaceflight. Potential CNS damage during a space mission could alter cognitive functions which might impact performance and individual’s health. The neuronal injury originating from exposure to 56Fe particle irradiation involves the elevated oxidative stress which can be inhibited by melatonin pretreatment. Melatonin exerts potent neuroprotective effects against carbon ion-induced mitochondrial dysfunction and apoptosis in the mouse brain. A significant increase in the count of immature neurons and proliferating cells was detected in the mice under 56Fe particle irradiation cotreated with the melatonin metabolite, AFMK. Melatonin treatment also significantly reduced the carbon ion-induced apoptotic cells and elevated oxidative stress in the mouse testis. The results suggest that melatonin treatment is a potential strategy to protect against space radiation hazards. Spaceflight-induced molecular, cellular, and physiologic changes lead to alterations across many organs and systems. Epigenetic, gene expression, inflammatory, and metabolic responses to spaceflight should be examined and means to safe-guard against these changes in upcoming missions. Precision medicine will be crucial for assessing and augmenting efficacy of melatonin or other medications in astronauts. In addition, enhancing radio-resistance of humans is a novel strategy for a long-term space mission. Further investigations with a combination of melatonin and other novel technologies are warranted to better alleviate HZE particle irradiation-induced damage to astronauts on long-term space exploration missions.
Key words: Melatonin, space exploration, galactic cosmic radiation, solar particle events, high-LET radiation, radio-resistance, CNS.
___________________________________________________________________________
1. INTRODUCTION
In recent years, technological advances and space missions have reached the point where the general public is considering traveling to outer space and voyages to Mars may become a reality in the near future. Nevertheless, one of the major problems with space travel is the exposure to galactic cosmic rays (GCR) which consists of high-energy protons and high charge (Z) and energy (E) (HZE) nuclei and solar particle events (SPE) which contains numerous low to medium energy protons (1). The GCR spectrum consists of about 1% electrons, 85% to 90% protons, 10% to 13% helium ions, and about 1% HZE particles (2), while GCR energy has a wide range from 0.001 to 1014 GeV/n, with a peak at 0.1 to 1 GeV/n (3, 4). GCR nuclei are high-LET particles, holding sufficient energies to penetrate any shielding technology employed on contemporary space vehicles (5). The SPE generally consists of 92% protons with energy ranging from 0.01 to 10 GeV/n, 6% helium nuclei and less than 2% HZE particles with energy of several Mev (3). The intense ionization power of GCR ions and SPE containing high fluence and substantial amounts of energetic protons can cause a detrimental biological hazard to astronauts in spacecraft (6). The composition and energy range of GCR and SPE are listed in Table 1.
Table 1. The composition and energy range of galactic cosmic rays and solar particle events
Type of radiation |
HZE particles |
Protons |
Helium ions |
Electrons |
Energy range |
GCR |
1 % |
85-90 % |
10-13 % |
1 % |
0.01-1014 Gev/n Peak 0.1-1 Gev/n |
SPE |
2 % |
92 % |
6% |
- |
0.01-10 Gev/n |
GCR: galactic cosmic rays, SPE: solar particle events, HZE particles: high charge and energy particles.
In addition, ionizing radiation causes injury to normal tissues, leading to release of damage-associated molecular patterns (DAMPs), secretion of cytokines and chemokines, and activation of immune system (7). An acute inflammatory phase characterized by an activated pro-inflammatory response and vascular leakage occurs subsequently. A perpetual cytokine and chemokine cascade associated with the recruitment of different immune cells results in many degrees of inflammation (8, 9). TH1, TH17 lymphocytes and probably innate lymphoid cells contribute to inflammation (10, 11). A protracted excessive response characterized by activation, proliferation of these immune cells and cytokine secretion is capable of transforming the microenvironment of normal tissues towards the development of severe inflammation (10, 11).
What is needed for these situations is a broadly protective, readily available, easily self-administered, low-cost radiation protector that can be used for a long period of time with little or no serious side effects (12). Melatonin (N-acetyl-5-methoxytryptamine), an indole compound synthesized by the pineal gland and many other tissues is involved in various essential physiological processes (13-16). The protective effect of melatonin against radiation-induced DNA and chromosome damage has been demonstrated in both human (17-20) and experimental animal studies (21-24). Melatonin prevents the death of animals given what would normally be a lethal dose of ionizing radiation (12). Melatonin is an amphiphilic molecule and can easily enter all cells (25, 26). After oral administration, melatonin distributes throughout the body where it prevents radiation-induced damage (10). Melatonin has been safely administered in both physiological and pharmacological doses to humans and animals, and there is a consensus that it is a non-toxic and non-teratogenic molecule (12, 25).
In this review, we summarize the molecular mechanisms of melatonin protection against high-LET radiation. In addition, we discuss recent advances related to melatonin as a versatile radioprotector for interplanetary travel by crewed spacecraft.
2. THE EFFECTS OF MELATONIN ON HZE PARTICLE IRRADIATION INDUCED BRAIN DAMAGE
2.1. The effects of melatonin on mitochondrial dysfunction and apoptosis in the mouse brain induced by high-LET carbon ion irradiation.
In the brain, hundreds to thousands of mitochondria are present in a single neuron (27). Mitochondria possess a number of copies of the mitochondrial genome that is composed of a 16.5 kb circular DNA molecule (27). Mitochondria constitute a substantial part of the total cell volume (28). Accordingly, mitochondria are probably important targets of ionizing radiation (28). Ionizing radiation is able to induce numerous lesions in the mitochondrial DNA (29, 30). Ionizing radiation alters mitochondrial functions and induces production of ROS, leading to mitochondrial oxidative stress (28).
Melatonin can serve as the first-line antioxidant to protect against environmental and internal oxidative stress (31). Tan and Reiter summarized the data showing that mitochondria synthesize the potent antioxidant, melatonin (31). The melatonin synthetic enzyme serotonin N-acetyltransferase (SNAT) was immunocytochemically-identified in matrix and also in the intermembrane space of mitochondria almost 40 years ago (31). They also point out that others have identified melatonin membrane receptors, including MT1 and MT2, on mitochondrial membranes (31). The protective effects of melatonin against neuronal injury were proven to be mainly mediated by mitochondrial melatonin receptors rather than the cell surface membrane receptors (31). Melatonin is not only produced in mitochondria but is also metabolized in mitochondria via several pathways, including melatonin’s direct interaction with ROS to form a spectrum of metabolites (31).
Various investigations reveal that radiation at doses less than 1 Gy can increase oxidative stress in the brain (32, 33). Overproduction of ROS and reactive nitrogen species (RNS) contributes to destruction of cellular structures and induces apoptosis (32). Apoptosis is recognized as a fundamental process in the nervous system development and disease (34).
A variety of studies reveal that the cellular antioxidant response against ROS is regulated by the nuclear factor erythoid 2-related factor 2 (Nrf2) (35, 36). Nrf2 is a member of NF-E2 family of nuclear basic leucine zipper transcription factors used to eradicate oxidative stressors by binding to the antioxidant responsive element (ARE) or the electrophile-responsive element (EpRE) and is encoded for antioxidant enzymes (36-38).
Liu et al. (39) assess the neuroprotective mechanisms of melatonin against carbon ion-induced mitochondrial dysfunction and apoptosis in mouse brain. A significant increase in carbonyl and MDA levels were detected 12 hours after carbon ion irradiation in comparison with the control group, indicating that irradiation promotes the generation of ROS and oxidative stress (39). Melatonin at a concentration of 1, 5 or 10 mg/kg significantly suppressed the carbon ion-induced enhancement of protein carbonyl (PC) and MDA levels in a dose-dependent manner in mice (39). These results highlight melatonin’s ability to alleviate the oxidation of protein and lipids following carbon ion irradiation (39).
Superoxide dismutase (SOD) and catalase (CAT) activities and total antioxidant capability (TAC) were significantly suppressed by carbon ion irradiation in comparison with the control group. Melatonin significantly elevated the activities of SOD and CAT, TAC levels as well as the Nrf2 protein expression in a dose-dependent manner in irradiated mice (39).
Apoptotic cells in the mouse brain significantly increased after carbon ion irradiation which can be suppressed by melatonin also in a dose-dependent manner (39).
Carbon ion irradiation reduced Bax is a proapoptotic protein and Bcl-2 is an antiapoptotic protein. The Bax/Bcl-2 ratio is a fundamental determinant of cell death/survival through apoptosis. This ratio is reduced by carbon ion irradiation; however, melatonin preserves this ratio in a dose-dependent manner (39).
Mice exposed to carbon ion irradiation significantly decreased Rh123 staining, indicating a reduction in ΔΨm (mitochondrial membrane potential). Decreased ΔΨm level is related to mitochondrial dysfunction and subsequent cell death. This alteration also can be prevented by melatonin treatment (39).
Furthermore, carbon ion irradiation induced a significant elevation of cytosolic cytochrome c content, the expression of caspase-3 and its cleavage product. Melatonin at a concentration of 1, 5 or 10 mg/kg suppressed the cytosolic cytochrome c content, the expression of caspase-3 and its cleavage product in irradiated mice (39).
The results reveal that melatonin exerts favorable neuroprotective effects against carbon ion-induced mitochondrial dysfunction and apoptosis in the mouse brain.
2.2. he effects of melatonin on oxidative damage and cell death in the mouse brain induced by high-LET 56Fe particle irradiation.
Manda et al. investigated the effects of melatonin on oxidative damage and cell death in the mouse brain induced by high-LET 56Fe particle irradiation (40). Increased necrosis in Purkinje cells and apoptosis of granule cells were detected following 56Fe particle irradiation. Significant reduction in the number of necrotic Purkinje cells and apoptotic granule cells was detected in irradiated mice pretreated with melatonin at a concentration of 10 mg/kg (40).
In different studies, DNA breakage as measured by the comet assay was found in mice following 56Fe exposure. Significant reduction in comet tail length and % DNA in comet tails was achieved by melatonin pretreatment in the irradiated mice. Melatonin also significantly inhibited 56Fe radiation-induced increase in 8-hydroxy-2'-deoxyguanosine (8-OHdG) level, an indicator of oxidative stress (40). Malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE), the products of lipid peroxidation, are extremely harmful to cells (41-42). Melatonin pretreatment significantly inhibited 56Fe radiation-induced elevations of malondialdehyde (MDA) + 4-hydroxyalkenal (4-HAE) and protein carbonyl (PC) level in the cerebellum of mice (40). Pretreatment with melatonin preserves the levels of nonprotein sulfhydryl (NP-SH), an indicator of GSH content and FRAP (ferric reducing antioxidant power of plasma) value, an indicator of total antioxidant capacity (TAC), following56Fe radiation (40).
Thus, brain oxidative damage following high energy charged particle radiation can be efficiently prevented by melatonin pretreatment.
The assessment of the effect of melatonin on charged particle induced brain damage is summarized in Table 2.
Table 2. Assessment of the effects of melatonin on charged particle irradiation induced brain damage.
Parameters |
Groups |
Results |
Reference |
8-OHdG level |
Control, Mel, IR, Mel + IR |
Mel + IR shows a significantly lower 8-OHdG value compared to IR. |
40 |
PC |
*Control, IR, Mel (1mg, 5mg, 10 mg/kg) + IR # Control, Mel, IR, Mel + IR
|
*Mel + IR shows a significantly lower PC value in a dose-dependent manner compared to IR. #Mel + IR shows a significantly lower PC value compared to IR. |
39
40 |
MDA |
Control, IR, Mel (1mg, 5mg, 10 mg/kg) + IR |
Mel + IR shows a significantly lower MDA value in a dose-dependent manner compared to IR. |
39 |
MDA+ HAE |
Control, Mel,IR, Mel + IR |
Mel + IR shows a significantly lower MDA + HAE value compared to IR. |
40 |
SOD, CAT and TAC |
Control, IR, Mel (1mg, 5mg, 10 mg/kg) + IR |
Mel + IR shows a significantly higher SOD, CAT and TAC value in a dose-dependent manner compared to IR. |
39 |
NP-SH |
Control, Mel, IR, Mel + IR |
Mel + IR shows a significantly higher NP-SH value compared to IR. |
40 |
FRAP |
Control, Mel, IR, Mel + IR |
Mel + IR shows a significantly higher FRAP value compared to IR. |
40 |
Nrf2 expression |
Control, IR, Mel (1mg, 5mg, 10 mg/kg) + IR |
Mel + IR shows a significantly higher Nrf2 value in a dose-dependent manner compared to IR. |
39 |
Apoptotic cells |
*Control, IR, Mel (1mg, 5mg, 10 mg/kg) + IR #Control, Mel, IR, Mel + IR
|
*Mel + IR shows a significantly lower number of apoptotic cells in a dose-dependent manner compared to IR. #Mel + IR shows a significantly lower number of apoptotic granule cells compared to IR. |
39
40 |
Bax/Bcl-2 ratio |
Control, IR, Mel (1mg, 5mg, 10 mg/kg) + IR |
Mel + IR shows a significant reduction of Bax/Bcl-2 ratio in a dose-dependent manner compared to IR. |
39 |
ΔΨm |
Control, IR, Mel (1mg, 5mg, 10 mg/kg) + IR |
Mel + IR shows a significantly higher ΔΨm value in a dose-dependent manner compared to IR. |
39 |
Cytochrome c, caspase-3 and its cleavage |
Control, IR, Mel (1mg, 5mg, 10 mg/kg) + IR |
Mel + IR shows a significantly lower value of cytochrome c, caspase-3 and its cleavage in a dose-dependent manner compared to IR. |
39 |
8-OHdG: 8-hydroxy-2'-deoxyguanosine, PC: protein carbonyl, MDA: Malondialdehyde, HAE: 4-hydroxyalkenal, SOD: superoxide dismutase, CAT: Catalase, TAC: Total antioxidant capacity, NP-SH: nonprotein sulfhydryl, FRAP: ferric reducing antioxidant power of plasma, Nrf2: the nuclear factor erythoid 2-related factor 2, ΔΨm: mitochondrial membrane potential, IR: Irradiation only group, Mel: melatonin (10 mg/kg) only group, Mel (1mg, 5mg, 10 mg/kg) + IR: Treatment with melatonin 1 mg/kg, 5 mg/kg and 10 mg/kg before irradiation respectively.
2.3. The effects of melatonin metabolite, AFMK, on neurogenesis damage induced by high-LET 56Fe particle irradiation in the hippocampal dentate gyrus.
The dentate gyrus of the hippocampus persists in producing new neurons in the adult mammalian brain. Memory functions are related to the pyramidal and granule cells of the dentate gyrus (43). New granule cells are generated from neuronal precursor in the subgranular zone (SGZ). These new cells then move to the granular cell layer (GCL) (43). Neuronal exposure to space radiation may cause a variety of dysfunctional outcomes. Recent evidence indicates that neuronal precursor cells in the hippocampus may be vulnerable to space radiation (44).
N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK), a melatonin metabolite, is an infrequently explored biogenic amine. The fundamental principle of kynurenic pathway of AFMK formation is that melatonin interacts with 1O2 and H2O2 to generate AFMK, which is converted to N1-acetyl-5-methoxykynuramine (AMK) by catalase. AFMK is a principal metabolite of melatonin oxidation (43). Manda et al. investigated the effect of the melatonin metabolite, AFMK, on neurogenesis damage in the hippocampal dentate gyrus induced by high-LET 56Fe particle irradiation (43).
Immature neurons (Dcx positive) and proliferating Ki-67-positive cells were evaluated in the dentate gyrus. A significant reduction of Dcx positive cells and Ki-67 positive cells was detected in irradiated mice as compared to the control. This reduction is prevented by AFMK at a concentration of 10 mg/kg (43).
Oxidative stress in the brain was usually assessed by levels of malondialdehyde + 4-hydroxyalkenal (MDA + HAE) and protein carbonyl. In brain homogenates of irradiated mice, there was significantly higher levels of MDA + HAE and protein carbonyl as compared to the control. AFMK pretreatment significantly lowers levels of MDA + HAE and protein carbonyl in irradiated mice (43).
Antioxidant status was assessed by TAC level and nonprotein sulfhydryl (NP-SH) content in the brain. There was a significant reduction of TAC level and NP-SH content in irradiated mice and AFMK pretreatment significantly increase of TAC level and NP-SH content (43).
The results indicate that AFMK pretreatment exerts neuroprotective effects against 56Fe particle irradiation induced inhibition of neurogenesis in the hippocampal dentate gyrus.
The assessment of the effects of the melatonin metabolite, AFMK, on 56Fe particle irradiation induced neurogenesis damage is summarized in Table 3.
Table 3. Assessment of the effects of the melatonin metabolite, AFMK, on 56Fe particle irradiation induced neurogenesis damage.
Parameters |
Groups |
Results |
Dcx positive cells |
Control, AFMK, IR, AFMK + IR |
AFMK + IR shows a significantly higher count of Dcx positive cells compared to IR. |
Ki-67 positive cells |
Control, AFMK, IR, AFMK + IR |
AFMK + IR shows a significantly higher count of Ki-67 positive cells compared to IR. |
PC |
Control, AFMK, IR, AFMK + IR |
AFMK + IR shows a significantly lower PC level compared to IR. |
MDA + HAE |
Control, AFMK, IR, AFMK + IR |
AFMK + IR shows a significantly lower MDA + HAE level compared to IR. |
NP-SH |
Control, AFMK, IR, AFMK + IR |
AFMK + IR shows a significantly higher NP-SH value compared to IR. |
TAC |
Control, AFMK, IR, AFMK + IR |
AFMK + IR shows a significantly higher TAC level compared to IR. |
Dcx: Doublecortin, AFMK: AFMK (10 mg/kg) only group, AFMK + IR: Treatment with melatonin 10 mg/kg before irradiation.
3. THE EFFECTS OF MELATONIN ON TESTICULAR DAMAGE INDUCED BY CARBON ION IRRADIATION
Space travel poses potential hazards to the reproductive system including testis (45). The testis is one of the most radiosensitive organs in the body (46). Space radiation contains highly charged and energy (HZE) particles (45). Consequently, there is a need for evaluation of the protection of the testis against charged particle radiation.
Liu et al. investigated the effects of melatonin on testicular damage induced by high-LET carbon ion irradiation. The comet assay was used to evaluate DNA breakage in mice following carbon ion exposure. Melatonin (10 mg/kg) treatment significantly reduced the carbon ion-induced DNA damage in both groups either melatonin pretreatment or melatonin posttreatment with IR (46).
Melatonin treatment significantly inhibited carbon ion-induced increase in the percentage of apoptotic cells in all of the melatonin plus irradiation groups including melatonin (1 mg/kg) pretreatment +IR, melatonin (10 mg/kg) pretreatment and posttreatment +IR , respectively(46).
Irradiation induced a significant increase in malondialdehyde (MDA) level, and a significant reduction of both glutathione (GSH) and total antioxidant capability (TAC) level and all these alterations are reversed by melatonin treatment (46).
The data support recommendation of melatonin treatment being used to protect against carbon ion-induced testicular damage.
The assessment of effects of melatonin on carbon ion-induced testicular damage is summarized in Table 4.
Table 4. Assessment of the effects of melatonin on carbon ion-induced testicular damage.
Parameters |
Groups |
Results |
MDA |
Control, Mel, IR, Mel pretreatment 1 mg/kg + IR, Mel pretreatment 10 mg/kg + IR, Mel posttreatment 10 mg/kg + IR |
Mel + IR shows a significantly lower MDA level compared to IR. |
GSH |
Control, Mel, IR, Mel pretreatment 1 mg/kg + IR, Mel pretreatment 10 mg/kg + IR, Mel posttreatment 10 mg/kg + IR |
Mel + IR shows a significantly higher GSH level compared to IR. |
TAC |
Control, Mel, IR, Mel pretreatment 1 mg/kg + IR, Mel pretreatment 10 mg/kg + IR, Mel posttreatment 10 mg/kg + IR |
Mel + IR shows a significantly higher TAC level compared to IR. |
Apoptotic cells (percentage) |
Control, Mel, IR, Mel pretreatment 1 mg/kg + IR, Mel pretreatment 10 mg/kg + IR, Mel posttreatment 10 mg/kg + IR |
Mel + IR shows a significantly lower percentage compared to IR. |
GSH: glutathione, Mel pretreatment 1 mg/kg + IR: Pretreatment with melatonin 1 mg/kg before irradiation, Mel pretreatment 10 mg/kg + IR: Pretreatment with melatonin 10 mg/kg before irradiation, Mel postreatment 10 mg/kg + IR: Treatment with melatonin 10 mg/kg after irradiation.
The results suggest that melatonin treatment is a potential strategy to protect against space radiation hazards.
4. CONCLUSION AND PERSPECTIVE
During interplanetary space travel, the central nervous system (CNS) and other organs are exposed to galactic cosmic rays and solar particle events (1, 47). NASA’s radiation standard limits astronaut exposures to a 3% risk of exposure induced death (REID) at the upper 95% confidence interval (CI) of the risk estimate (1). Fatal cancer risk has been considered the dominant risk for space radiation. Risks to the central nervous system (CNS) and other organs are also a concern (1). Potential CNS damage during a space mission could alter cognitive functions which may impact performance and individual’s health (48). The neuronal injury originating from exposure to 56Fe particle irradiation involves damage from elevated oxidative stress which can be prevented by melatonin pretreatment (40). Melatonin exerts potent neuroprotective effects against carbon ion-induced mitochondrial dysfunction and apoptosis in mouse brain (39). A significant increase in the count of immature neurons and proliferating cells was detected in the 56Fe particle irradiated mice pretreated with AFMK at a concentration of 10 mg/kg, indicating that AFMK enhanced neurogenesis in hippocampal dentate gyrus (43). Melatonin treatment also significantly alleviated the carbon ion-induced increase in the percentage of apoptotic cells and elevated oxidative stress in mouse testis. (46). The results suggest that melatonin treatment is a potential strategy to protect against space radiation hazards.
Melatonin meets various criteria as an appropriate radioprotector for the spacefaring population. Firstly, any useful medication should have a history of safe application in humans with minimal or negligible side effects. Secondly, possible side effects of the medication should be easily observed by an astronaut with minimal skill of health care. Thirdly, the medication itself should be easily administered (preferably via the oral route) and should have a long shelf life in the space environment (49). Spaceflight-induced molecular, cellular, and physiologic changes lead to alterations across many organs and systems. Epigenetic, gene expression, inflammatory, and metabolic responses to spaceflight should be examined and means to safe-guard against these changes should be made in upcoming missions. Precision medicine will be crucial for assessing and augmenting efficacy of melatonin or other medications in astronauts (50).
In addition, enhancing radioresistance of humans is a novel strategy for the purpose of interplanetary space travel. Many organisms exhibit high degrees of radioresistance against high doses of radiation (51). Elucidating the genes and molecular mechanisms conferring such high degrees of radioresistance and translating to humans through genetic engineering would constitute an effective strategy to enhance radioresistance in humans (52). Ramazzottius varieornatus is one of the most radioresistant species in tardigrades (51). A recent study identified a nuclear protein capable of protecting DNA from the damaging effects of ionizing radiation in Ramazzottius varieornatus, termed damage suppressor (Dsup) (53). The human cultured HEK293 cells exposed to 10 Gy of X-ray irradiation revealed that the transfected cells had roughly half as many DNA single-strand breaks as the control group. The neutral comet assay and analysis of the number of γ-H2AX foci (an indicator of double-strand breaks) showed a 40% reduction in DNA fragmentation in the transfected cells compared to the control group. The human cells lost proliferative ability following 3-7 Gy of X-ray irradiation. Following 4 Gy X-ray irradiation the transfected cells had slightly increased viability and higher proliferative ability than the irradiated control cells (53). Therefore, the delivery and expression of Dsup transgenes in vivo represent an encouraging candidate for potential exogenous radioprotective transgenes that would assist in establishing enhanced radioresistance in humans for the intention of deep space exploration (52). Mechanistically, the Dsup is a nucleosome-binding protein that protects chromatin from hydroxyl radicals (54). Melatonin accordantly is the most powerful hydroxyl radical scavenger found in all most of the organisms (55). Thus, further investigations with a combination of melatonin and other novel technologies are warranted to better alleviate HZE particle irradiation-induced damage to healthy tissues of astronauts on long-term space exploration missions. The potential mechanisms of melatonin’s protection against the high-LET radiation in CNS are illustrated in the Figure 1.
Fig. 1. The potential mechanisms of melatonin’s protection against high LET radiation in CNS.
ROS: reactive oxygen species, NO: nitric oxide, SOD: Superoxide dismutase CAT: catalase, arrows: promotion, T type symbol: inhibition.
ACKNOWLEDGEMENT
None
AUTHORSHIP
RJR conceived the idea and produced an outline. This was then discussed with the co-author during which time he submitted ideas for inclusion. Both co-authors read preliminary and the final versions of the manuscript.
CONFLICT INTEREST
The authors declare no conflicts of interest.
REFERENCES
Cucinotta FA, Kim MH, Chappell LJ, et al. (2013) How safe is safe enough? Radiation risk for a human mission to Mars. PLoS One 8: e74988.
Simpson JA (1983) Elemental and isotopic composition of the galactic cosmic rays. Ann. Rev. Nucl. Part. Sci. 33: 323-381.
Maalouf M, Durante M, Foray N (2011) Biological effects of space radiation on human cells: history, advances and outcomes. J. Radiat. Res. 52: 126-146.
Nelson GA (2016) Space radiation and human exposures, a primer. Radiat. Res. 185: 349-358.
Kim MH, Wilson JW, Cucinotta FA (2012) Description of transport codes for space radiation shielding. Health Phys. 103: 621-639.
Chancellor JC, Scott GB, Sutton JP (2014) Space Radiation: The number one risk to astronaut health beyond low Earth orbit. Life (Basel) 4: 491-510.
Guipaud O, Jaillet C, Clément-Colmou K, et al. (2018) The importance of the vascular endothelial barrier in the immune-inflammatory response induced by radiotherapy. Br. J. Radiol. 91: 20170762.
Schaue D, Kachikwu EL, McBride WH (2012) Cytokines in radiobiological responses: a review. Radiat. Res. 178: 505-523.
Werner E, Wang H, Doetsch PW (2015) Role of pro-inflammatory cytokines in radiation-induced genomic instability in human bronchial epithelial cells. Radiat. Res. 184: 621-629.
Schaue D, McBride WH (2012) T lymphocytes and normal tissue responses to radiation. Front. Oncol. 2: 119.
Wirsdörfer F, Jendrossek V (2016) The role of lymphocytes in radiotherapy-induced adverse late effects in the lung. Front. Immunol. 7: 591.
Reiter RJ, Tan DX, Korkmaz A, et al. (2011) The disaster in Japan: utility of melatonin in providing protection against ionizing radiation. J. Pineal Res. 50: 357-358.
Reiter RJ, Rosales-Corral S, Tan DX, et al. (2017) Melatonin as a mitochondria-targeted antioxidant: one of evolution's best ideas. Cell Mol. Life Sci. 74: 3863-3881.
Reiter RJ, Tan DX, Rosales-Corral S, et al. (2018) Mitochondria: central organelles for melatonin's antioxidant and anti-aging actions. Molecules 23: 509-533.
Manchester LC, Coto-Montes A, Boga JA, et al. (2015) Melatonin: an ancient molecule that makes oxygen metabolically tolerable. J. Pineal Res. 59: 403-419.
Reiter RJ, Ma Q, Sharma R (2020) Melatonin in mitochondria: Mitigating clear and present dangers. Physiology (Bethesda) 35: 86-95.
Kouhi Habibi N, Shabestani Monfared A, Ebrahimnejad Gorji K, et al. (2019) The protective effects of melatonin on blood cell counts of rectal cancer patients following radio-chemotherapy: a randomized controlled trial. Clin. Transl. Oncol. 21: 745-752.
Vijayalaxmi, Reiter RJ, Meltz ML (1995) Melatonin protects human blood lymphocytes from radiation-induced chromosome damage. Mutat. Res. 346: 23-31.
Vijayalaxmi, Reiter RJ, Herman TS, et al. (1996) Melatonin and radioprotection from genetic damage: in vivo/in vitro studies with human volunteers. Mutat. Res. 37: 221-228.
Vijayalaxmi, Reiter RJ, Herman TS, et al. (1998) Melatonin reduces gamma-radiation-induced primary DNA damage in human blood lymphocytes. Mutat. Res. 347: 203-208.
Vijayalaxmi, Meltz ML, Reiter RJ, et al. (1999) Melatonin and protection from whole-body irradiation: survival studies in mice. Mutat. Res. 425: 21-27.
Vijayalaxmi, Meltz ML, Reiter RJ, et al. (1999) Melatonin and protection from genetic damage in blood and bone marrow: whole-body irradiation studies in mice. J. Pineal Res. 27: 221-225.
Musa AE, Shabeeb D, Alhilfi HSQ (2019) Protective effect of melatonin against radiotherapy-induced small intestinal oxidative stress: biochemical evaluation. Medicina (Kaunas). 55: 308-318.
Shabeeb D, Najafi M, Musa AE, et al. (2019) Biochemical and histopathological evaluation of the radioprotective effects of melatonin against gamma ray-induced skin damage. Curr. Radiopharm. 12: 72-81.
Korkmaz A, Tan DX, Reiter RJ (2011) Melatonin: an established radioprotective agent against Japan’s nuclear disaster. TAF Prev. Med. Bull. 10: 127-129.
Tarocco A, Caroccia N, Morciano G. et al. (2019) Melatonin as a master regulator of cell death and inflammation: molecular mechanisms and clinical implications for newborn care. Cell Death Dis. 10: 317-328.
Rango M, Bresolin N (2018) Brain mitochondria, aging, and Parkinson's disease. Genes (Basel). 9: 250.
Livingston K, Schlaak RA, Puckett LL, et al. (2020) The role of mitochondrial dysfunction in radiation-induced heart disease: from bench to bedside. Front. Cardiovasc. Med. 7:20.
Rogounovitch TI, Saenko VA, Shimizu-Yoshida Y, et al. (2002) Large deletions in mitochondrial DNA in radiation-associated human thyroid tumors. Cancer Res. 62: 7031-7041.
Wilding CS, Cadwell K, Tawn EJ, et al. (2006) Mitochondrial DNA mutations in individuals occupationally exposed to ionizing radiation. Radiat. Res. 165: 202-207.
Tan DX, Reiter RJ (2019) Mitochondria: the birth place, battle ground and the site of melatonin metabolism in cells. Melatonin Res. 2: 44-66.
Mao XW, Boerma M, Rodriguez D, et al. (2018) Acute effect of low-dose space radiation on mouse retina and retinal endothelial cells. Radiat. Res. 190: 45-52.
Zhang Y, Wang Q, Chen H, et al. (2018) Involvement of cholinergic dysfunction and oxidative damage in the effects of simulated weightlessness on learning and memory in rats. Biomed. Res. Int. 2018: 2547532.
Majidinia M, Reiter RJ, Shakouri SK, et al. (2018) The role of melatonin, a multitasking molecule, in retarding the processes of ageing. Ageing Res. Rev. 47: 198-213.
Dong J, Sulik KK, Chen SY (2008) Nrf2-mediated transcriptional induction of antioxidant response in mouse embryos exposed to ethanol in vivo: implications for the prevention of fetal alcohol spectrum disorders. Antioxid. Redox Signal 10: 2023-2033.
Ma YF, Wu ZH, Gao M, et al. (2018) Nuclear factor erythroid 2-related factor 2 antioxidant response element pathways protect bovine mammary epithelial cells against H2O2-induced oxidative damage in vitro. J. Dairy Sci. 101: 5329‐5344.
Raghunath A, Sundarraj K, Nagarajan R, et al. (2018) Antioxidant response elements: Discovery, classes, regulation and potential applications. Redox Biol. 17: 297-314.
Tonelli C, Chio IIC, Tuveson DA (2018) Transcriptional regulation by Nrf2. Antioxid. Redox Signal 29 :1727-1745.
Liu Y, Zhang L, Zhang H, et al. (2012) Exogenous melatonin modulates apoptosis in the mouse brain induced by high-LET carbon ion irradiation. J. Pineal Res. 52: 47-56.
Manda K, Ueno M, Anzai K.(2008) Melatonin mitigates oxidative damage and apoptosis in mouse cerebellum induced by high-LET 56Fe particle irradiation. J. Pineal Res. 44: 189-196.
Xiao M, Zhong H, Xia L, et al. (2017) Pathophysiology of mitochondrial lipid oxidation: Role of 4-hydroxynonenal (4-HNE) and other bioactive lipids in mitochondria. Free Radic. Biol. Med. 111: 316-327.
Sousa BC, Pitt AR, Spickett CM (2017) Chemistry and analysis of HNE and other prominent carbonyl-containing lipid oxidation compounds. Free Radic. Biol. Med. 111: 294-308.
Manda K, Ueno M, Anzai K (2008) Space radiation-induced inhibition of neurogenesis in the hippocampal dentate gyrus and memory impairment in mice: ameliorative potential of the melatonin metabolite, AFMK. J. Pineal Res. 45: 430-438.
Tseng BP, Giedzinski E, Izadi A, et al. (2014) Functional consequences of radiation-induced oxidative stress in cultured neural stem cells and the brain exposed to charged particle irradiation. Antioxid. Redox Signal 20: 1410-1422.
Mishra B, Luderer U (2019) Reproductive hazards of space travel in women and men. Nat. Rev. Endocrinol. 15: 713-730.
Liu Y, Zhang H, Zhang L, et al. (2009) Melatonin modulates acute testicular damage induced by carbon ions in mice. Pharmazie 64: 685-689.
Cucinotta FA, Cacao E (2019) Risks of cognitive detriments after low dose heavy ion and proton exposures. Int. J. Radiat. Biol. 95: 985-998.
Cucinotta FA, Alp M, Sulzman FM, et al. (2014) Space radiation risks to the central nervous system. Life Sci. Space Res. 2: 54-69.
McLaughlin MF, Donoviel DB, Jones JA (2017) Novel indications for commonly used medications as radiation protectants in spaceflight. Aerosp. Med. Hum. Perform. 88: 665-676.
Iosim S, MacKay M, Westover C, et al. (2019) Translating current biomedical therapies for long duration, deep space missions. Precis. Clin. Med. 2: 259-269.
Furukawa S, Nagamatsu A, Nenoi M, et al. (2020) Space radiation biology for "Living in Space". Biomed. Res. Int. 2020: 4703286.
Cortese F, Klokov D, Osipov A, et al. (2018) Vive la radiorésistance!: converging research in radiobiology and biogerontology to enhance human radioresistance for deep space exploration and colonization. Oncotarget. 9:14692-14722.
Hashimoto T, Horikawa DD, Saito Y, et al. (2016) Extremotolerant tardigrade genome and improved radiotolerance of human cultured cells by tardigrade-unique protein. Nat. Commun. 7:12808.
Chavez C, Cruz-Becerra G, Fei J, et al. (2019) The tardigrade damage suppressor protein binds to nucleosomes and protects DNA from hydroxyl radicals. Elife. 8: e47682.
Tan DX, Chen LD, Poeggeler B, et al. (1993) Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr. J. 1: 57-60.
This work is licensed under a Creative Commons Attribution 4.0 International License